Congenital factor V deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:326OMIM:227400D68.2
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital factor V deficiency, also known as Owren disease or parahemophilia, is a rare inherited bleeding disorder caused by a deficiency or dysfunction of coagulation factor V (also called labile factor or proaccelerin). Factor V plays a critical role in the blood clotting cascade, serving as an essential cofactor for factor Xa in the conversion of prothrombin to thrombin. Without adequate functional factor V, the body's ability to form stable blood clots is significantly impaired. The severity of bleeding symptoms generally correlates with the level of residual factor V activity. Patients with severe deficiency (factor V levels below 1%) may present in the neonatal period or early childhood with serious bleeding manifestations including intracranial hemorrhage, umbilical cord bleeding, and gastrointestinal hemorrhage. More moderate forms may present with epistaxis (nosebleeds), easy bruising, menorrhagia (heavy menstrual bleeding) in women, prolonged bleeding after surgery or dental procedures, and mucocutaneous bleeding. Joint bleeding (hemarthrosis) and muscle hematomas, while characteristic of other clotting factor deficiencies, are less common in factor V deficiency but can occur in severe cases. There is no factor V concentrate currently available for treatment. Management of bleeding episodes and surgical prophylaxis relies primarily on fresh frozen plasma (FFP), which contains factor V. Platelet transfusions may also be beneficial since platelets contain approximately 20% of the body's factor V in their alpha granules. Antifibrinolytic agents such as tranexamic acid can be used as adjunctive therapy, particularly for mucosal bleeding. Women with heavy menstrual bleeding may benefit from hormonal therapies. Patients are advised to avoid antiplatelet medications and to coordinate with a hematologist for any planned surgical or dental procedures.

Also known as:

Clinical phenotype terms— hover any for plain English:

Persistent bleeding after traumaHP:0001934Prolonged bleeding after surgeryHP:0004846Prolonged bleeding after dental extractionHP:0006298Spontaneous hematomasHP:0007420Prolonged bleeding following procedureHP:0011890Post-partum hemorrhageHP:0011891Prolonged bleeding following circumcisionHP:0030137Oral cavity bleedingHP:0030140HematocheziaHP:0002573MetrorrhagiaHP:0100608
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Feb 2020Evaluation of a Screening Strategy of Fabry Disease in Patient With Renal Biopsy

University Hospital, Angers — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Congenital factor V deficiency.

View clinical trials →

No actively recruiting trials found for Congenital factor V deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital factor V deficiency community →

Specialists

16 foundView all specialists →
MS
Mohammad Shirzadi
Specialist
1 Congenital factor V deficiency publication
JW
Jun Wu
Specialist
1 Congenital factor V deficiency publication
AB
Arnaud Bonnefoy
Specialist
1 Congenital factor V deficiency publication
MP
Marie-Claude Pelland-Marcotte
Specialist
1 Congenital factor V deficiency publication
HL
Hsuan-Yu Lin
Specialist
1 Congenital factor V deficiency publication
CL
Ching-Yeh Lin
Specialist
1 Congenital factor V deficiency publication
SK
Su-Feng Kuo
Specialist
1 Congenital factor V deficiency publication
JL
Jen-Shiou Lin
Specialist
1 Congenital factor V deficiency publication
PL
Po-Te Lin
Specialist
1 Congenital factor V deficiency publication
YH
Ying-Chih Huang
Specialist
1 Congenital factor V deficiency publication
HH
Han-Ni Hsieh
Specialist
1 Congenital factor V deficiency publication
MS
Ming-Ching Shen
Specialist
1 Congenital factor V deficiency publication
HZ
Haiyue Zhang
Specialist
1 Congenital factor V deficiency publication
CG
Clara Guilbault
Specialist
1 Congenital factor V deficiency publication
GR
Georges-Étienne Rivard
Specialist
1 Congenital factor V deficiency publication
JA
Jean-François AUGUSTO
Angers
Specialist

Rare Disease Specialist

3 Congenital factor V deficiency publications

Treatment Centers

8 centers
⚗️ Trial Site

CHU Angers

📍 Angers

👤 Julien Rossignol, Dr

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Travel Grants

No travel grants are currently matched to Congenital factor V deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital factor V deficiencyForum →

No community posts yet. Be the first to share your experience with Congenital factor V deficiency.

Start the conversation →

Latest news about Congenital factor V deficiency

Disease timeline:

New trial: Evaluation of a Screening Strategy of Fabry Disease in Patient With Renal Biopsy

Phase NA trial recruiting. Detection of Fabry disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital factor V deficiency

What is Congenital factor V deficiency?

Congenital factor V deficiency, also known as Owren disease or parahemophilia, is a rare inherited bleeding disorder caused by a deficiency or dysfunction of coagulation factor V (also called labile factor or proaccelerin). Factor V plays a critical role in the blood clotting cascade, serving as an essential cofactor for factor Xa in the conversion of prothrombin to thrombin. Without adequate functional factor V, the body's ability to form stable blood clots is significantly impaired. The severity of bleeding symptoms generally correlates with the level of residual factor V activity. Patients

How is Congenital factor V deficiency inherited?

Congenital factor V deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Congenital factor V deficiency?

16 specialists and care centers treating Congenital factor V deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.